Cambridge, United Kingdom

Angelica Mariani

USPTO Granted Patents = 5 

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Angelica Mariani

Introduction

Angelica Mariani is a prominent inventor based in Cambridge, GB. She has made significant contributions to the field of biotechnology, particularly in the area of nucleotide sequencing. With a total of five patents to her name, Mariani's work has advanced the methodologies used in genetic research and sequencing applications.

Latest Patents

Among her latest patents, Mariani has developed methods of sequencing using nucleotides with a 3' acetal blocking group. These embodiments relate to nucleotides that feature acetal 3'-OH blocking groups, providing innovative methods for sequencing applications. Additionally, she has patented nucleotide molecules with a 3' AOM blocking group, which includes methods for preparing these nucleotide molecules and their uses in sequencing applications.

Career Highlights

Angelica Mariani is currently employed at Illumina Cambridge Limited, a leading company in the field of genomics. Her work at Illumina has positioned her as a key player in the development of advanced sequencing technologies. Mariani's expertise and innovative spirit have contributed to the company's reputation for excellence in genetic research.

Collaborations

Some of her notable coworkers include Antoine Francais and Elena Cressina. Their collaborative efforts have further enhanced the research and development initiatives at Illumina Cambridge Limited.

Conclusion

Angelica Mariani's contributions to nucleotide sequencing and her innovative patents have made a significant impact in the field of biotechnology. Her work continues to influence advancements in genetic research and sequencing methodologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…